Boston Scientific (BSX)

Cost of Revenue

$1.59B

Quarterly · Period ending: · USD

BSX logo

BSX Cost of Revenue

Latest reported$1.59B
BSX Quarterly Cost of Revenue ($0.00 → $1.59B)
High-resolution chart · PNG

BSX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
268,000,000
222,000,000
112,000,000
200,000,000
217,000,000
213,000,000
152,000,000
283,000,000
235,000,000
230,000,000
167,300,000
200,500,000
151,200,000
140,000,000
75,300,000
135,900,000
131,500,000
113,200,000
54,600,000
104,500,000
94,900,000
85,600,000
80,800,000
65,600,000
66,200,000
64,400,000
34,500,000
41,200,000
40,000,000
37,400,000
35,200,000
33,600,000
32,900,000
32,200,000
30,600,000
28,500,000
27,000,000
25,700,000
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.